-+ 0.00%
-+ 0.00%
-+ 0.00%

ALLARITY THERAPEUTICS ANNOUNCES THAT ITS COLLABORATIVE PHASE 2 TRIAL WITH THE UNITED STATES VETERAN’S ADMINISTRATION COMBINING STENOPARIB WITH TEMOZOLOMIDE IN RELAPSED SMALL CELL LUNG CANCER IS NOW OPEN FOR ENROLLMENT

Reuters·02/03/2026 13:00:52

Please log in to view news